A multidisciplinary team at the University of Miami Miller School of Medicine has developed a breakthrough nanodrug platform that may prove beneficial for rapid, targeted therapeutic hypothermia after traumatic brain injury (TBI).
Their work, published in ACS Applied Materials & Interfaces, demonstrates that intranasal nanovanilloids can lower brain temperature by 2.0° C to 3.6° C for up to three hours in pre-clinical models. The results offer a promising new approach for protecting the brain at the point of injury.
“This work exemplifies how nanotechnology and neuroscience principles can be applied together to create therapeutic solutions for critical medical problems that have the potential of saving human lives,” said Sylvia Daunert, Ph.D., Lucille P. Markey Chair in Biochemistry and Molecular Biology and director at the Dr. John T. Macdonald Foundation Biomedical Nanotechnology Institute (BioNIUM), one of the study’s lead investigators.
Study Overview: From Chemistry to Clinical Potential
Vanilloids are natural compounds that activate the TRPV1 receptor, which is involved in pain, inflammation and body temperature regulation. The Miller School researchers created nanovanilloids using three cooling compounds: rinvanil, arvanil and olvanil. They used a special process that mixes the drug in alcohol with water while applying sound waves, which helps the particles form and stay evenly sized. Tests showed these particles are very small (all smaller than 200 nanometers), consistent in size and can stay stable for a long time at room temperature.
Importantly, these particles don’t need any extra carriers or coatings. The drug itself forms the particle. This means more medicine can be delivered safely and easily through the nose to reach the brain in a faster and more targeted manner.
The team checked if the nanovanilloids were safe for cells and didn’t cause stress or damage. They found that the particles didn’t harm cell health or increase stress levels. To make sure the nanovanilloid drugs worked as intended, they ran tests showing that the particles activated the target receptor, TRPV1, which is needed to trigger cooling in the brain.
Why the intranasal route?
Delivering the medicine through the nose lets it reach the brain quickly and avoids being filtered out by the body’s usual barriers. This means the treatment works faster and needs a smaller dose compared to giving it through an IV. The research team used a custom designed, 3D-printed spray nozzle to make sure the nanodrug was spread evenly and gently inside the nose.
The researchers also pointed out that similar nasal spray devices are already used for other brain medicines. These devices can be made safely and consistently by following standard manufacturing and quality controls.
Using the device, the team administered nanovanilloids and found:
• Nano-olvanil reduced head temperature by about 2 °C for more than 100 minutes for pre-clinical models with no injury.
• Nano-rinvanil achieved a 3.6 °C drop in brain temperature in pre-clinical models with moderate TBI, with core body temperature remaining stable. That indicated targeted brain cooling, and researchers confirmed no liver or kidney toxicity.
Implications for Patient Care
• Prehospital neuroprotection: Enables rapid brain cooling at the scene or during transport for TBI, spinal cord injury, stroke or heat-related illness.
• Targeted therapy: Localized cooling minimizes systemic side effects, a major limitation of traditional hypothermia methods.
• Scalable platform: The carrier-free nano-assembly approach can be adapted for other hydrophobic drugs, broadening its impact on acute neurological care.
“This approach offers a new pathway to protect the brain during the most critical window, with the potential to improve survival and recovery for patients,” said lead investigator Helen Bramlett, Ph.D., professor of neurological surgery at the Miller School and The Miami Project to Cure Paralysis.
Next Steps
The Miller School researchers plan to advance this technology toward clinical translation, including dose optimization, device compatibility and human factors testing. Their work sets the stage for innovative, patient-first neuroprotection strategies that could be deployed outside hospital settings.
“In my opinion, these results mark one of the most important technological developments in therapeutic hypothermia and targeted temperature management research over the past 30 years,” said W. Dalton Dietrich, Ph.D., scientific director of The Miami Project and professor of neurological surgery and senior associate dean for team science at the Miller School.
“It is important to highlight that the developed technology stems from a team science approach, and that without a multidisciplinary team of scientists, complex problems like this cannot be solved,” Dr. Daunert said.
The Miller School Research Team
The research team was led by Dr. Daunert, Dr. Dietrich, Dr. Bramlett and Sapna Deo, Ph.D., professor of biochemistry and molecular biology at the Miller School.
Other key contributors included:
• Emre Dikici, Ph.D., senior scientist and director of the Bionanotechnology Laboratory
• Alexia Kafkoutsou, a Ph.D. candidate in the Department of Biochemistry and Molecular Biology
• Jorge David Tovar, a Ph.D. candidate in the Department of Biochemistry and Molecular Biology
• Juliana Sànchez, M.D., assistant scientist at the Miami Project to Cure Paralysis
News
Miller School Researchers Pioneer Nanovanilloid-Based Brain Cooling for Traumatic Injury
A multidisciplinary team at the University of Miami Miller School of Medicine has developed a breakthrough nanodrug platform that may prove beneficial for rapid, targeted therapeutic hypothermia after traumatic brain injury (TBI). Their work, published in ACS [...]
COVID-19 still claims more than 100,000 US lives each year
Centers for Disease Control and Prevention researchers report national estimates of 43.6 million COVID-19-associated illnesses and 101,300 deaths in the US during October 2022 to September 2023, plus 33.0 million illnesses and 100,800 deaths [...]
Nanomedicine in 2026: Experts Predict the Year Ahead
Progress in nanomedicine is almost as fast as the science is small. Over the last year, we've seen an abundance of headlines covering medical R&D at the nanoscale: polymer-coated nanoparticles targeting ovarian cancer, Albumin recruiting nanoparticles for [...]
Lipid nanoparticles could unlock access for millions of autoimmune patients
Capstan Therapeutics scientists demonstrate that lipid nanoparticles can engineer CAR T cells within the body without laboratory cell manufacturing and ex vivo expansion. The method using targeted lipid nanoparticles (tLNPs) is designed to deliver [...]
The Brain’s Strange Way of Computing Could Explain Consciousness
Consciousness may emerge not from code, but from the way living brains physically compute. Discussions about consciousness often stall between two deeply rooted viewpoints. One is computational functionalism, which holds that cognition can be [...]
First breathing ‘lung-on-chip’ developed using genetically identical cells
Researchers at the Francis Crick Institute and AlveoliX have developed the first human lung-on-chip model using stem cells taken from only one person. These chips simulate breathing motions and lung disease in an individual, [...]
Cell Membranes May Act Like Tiny Power Generators
Living cells may generate electricity through the natural motion of their membranes. These fast electrical signals could play a role in how cells communicate and sense their surroundings. Scientists have proposed a new theoretical [...]
This Viral RNA Structure Could Lead to a Universal Antiviral Drug
Researchers identify a shared RNA-protein interaction that could lead to broad-spectrum antiviral treatments for enteroviruses. A new study from the University of Maryland, Baltimore County (UMBC), published in Nature Communications, explains how enteroviruses begin reproducing [...]
New study suggests a way to rejuvenate the immune system
Stimulating the liver to produce some of the signals of the thymus can reverse age-related declines in T-cell populations and enhance response to vaccination. As people age, their immune system function declines. T cell [...]
Nerve Damage Can Disrupt Immunity Across the Entire Body
A single nerve injury can quietly reshape the immune system across the entire body. Preclinical research from McGill University suggests that nerve injuries may lead to long-lasting changes in the immune system, and these [...]
Fake Science Is Growing Faster Than Legitimate Research, New Study Warns
New research reveals organized networks linking paper mills, intermediaries, and compromised academic journals Organized scientific fraud is becoming increasingly common, ranging from fabricated research to the buying and selling of authorship and citations, according [...]
Scientists Unlock a New Way to Hear the Brain’s Hidden Language
Scientists can finally hear the brain’s quietest messages—unlocking the hidden code behind how neurons think, decide, and remember. Scientists have created a new protein that can capture the incoming chemical signals received by brain [...]
Does being infected or vaccinated first influence COVID-19 immunity?
A new study analyzing the immune response to COVID-19 in a Catalan cohort of health workers sheds light on an important question: does it matter whether a person was first infected or first vaccinated? [...]
We May Never Know if AI Is Conscious, Says Cambridge Philosopher
As claims about conscious AI grow louder, a Cambridge philosopher argues that we lack the evidence to know whether machines can truly be conscious, let alone morally significant. A philosopher at the University of [...]
AI Helped Scientists Stop a Virus With One Tiny Change
Using AI, researchers identified one tiny molecular interaction that viruses need to infect cells. Disrupting it stopped the virus before infection could begin. Washington State University scientists have uncovered a method to interfere with a key [...]
Deadly Hospital Fungus May Finally Have a Weakness
A deadly, drug-resistant hospital fungus may finally have a weakness—and scientists think they’ve found it. Researchers have identified a genetic process that could open the door to new treatments for a dangerous fungal infection [...]
